EWM
Essex Woodlands Management Portfolio holdings
AUM $279M
1-Year Return
29.39%
This Quarter Return
+24.15%
1 Year Return
+29.39%
3 Year Return
+195.65%
5 Year Return
+90.32%
10 Year Return
+273.6%
AUM
$385M
AUM Growth
+$197M
(+105%)
Cap. Flow
+$178M
Cap. Flow
% of AUM
46.09%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
1
Closed
1
Top Buys
| 1 |
MiMedx Group
MDXG
|
+$178M |
Top Sells
| 1 |
ELGX
Endologix Inc
ELGX
|
+$3K |
| 2 |
EyePoint Pharmaceuticals
EYPT
|
+$7 |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
MiMedx Group
MDXG
$1.03B
| $178M | 46.09% |
+19,480,519
| New | +$178M |
|
|
RVNC
2
DELISTED
Revance Therapeutics, Inc.
RVNC
| $94.7M | 24.58% |
3,342,047
| – | – |
|
3
Axogen
AXGN
$774M
| $35.5M | 9.21% |
1,981,888
| – | – |
|
|
4
EyePoint Pharmaceuticals
EYPT
$940M
| $27.6M | 7.16% |
4,190,921
-1
| -0% | -$7 |
|
5
TELA Bio
TELA
$61.4M
| $22.2M | 5.76% |
1,475,293
| – | – |
|
6
Venus Concept
VERO
$4.37M
| $21.5M | 5.57% |
75,260
| – | – |
|
7
MediciNova
MNOV
$60.3M
| $5.82M | 1.51% |
1,105,941
| – | – |
|
8
Gyre Therapeutics
GYRE
$687M
| $496K | 0.13% |
10,483
| – | – |
|
|
ELGX
9
DELISTED
Endologix Inc
ELGX
| – | – |
-125,747
| Closed | -$3K |
|